Clinical Trial Update: Janssen - Glucose Regulation/Risp/Olanz [NA]

View source ↗

Summary

A Janssen-sponsored study evaluating glucose regulation in schizophrenia patients treated with risperidone or olanzapine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Risperdal (risperidone)
• Zyprexa (olanzapine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Schizophrenia, Type 2 Diabetes Mellitus | NA | Status: COMPLETED